LMAT vs RF
LeMaitre Vascular Inc (LMAT) versus RF (RF) — a side-by-side from cached financials, not a winner call.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
RF (RF) common stock.
Latest reported LMAT revenue for 2024-12-31 was $219.9M. Net income was $44.0M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
RF does not have a complete income-statement cache yet.
LMAT currently screens at market cap $2.16B and trailing P/E 34.8. RF currently screens at market cap $0.
Not investment advice. Open the LMAT and RF stock pages for the full models.
Not investment advice.